All-Cause and disease-specific mortality in hospitalized patients with clostridium difficile infection: A multicenter cohort study

Clinical Infectious Diseases

Volumn 56, Issue 8, 2013, Pages 1108-1116

  Hensgens, Marjolein P M ^a   Goorhuis, Abraham ^b   Dekkers, Olaf M ^a,c   Van Benthem, Birgit H B ^d   Kuijper, Ed J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Department of Clinical Epidemiology ^*  (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

CDI; Clostridium difficile infection; death rate; endemic; mortality

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT IDENTIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CAUSE OF DEATH; CLOSTRIDIUM DIFFICILE; COHORT STUDIES; DEATH CERTIFICATES; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INPATIENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MORTALITY; RISK;

EID: 84875648276     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis1209     Document Type: Article

References (30)

1. Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171:466-72. (Pubitemid 39179608)
2. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008; 46(suppl 1):S12-8. (Pubitemid 351323661)
3. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442-9. (Pubitemid 41770165)
4. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-41. (Pubitemid 41770164)
5. Kuijper EJ, van den Berg RJ, Debast S, et al. Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis 2006; 12:827-30. (Pubitemid 43726862)
6. Goorhuis A, van der KT, Vaessen N, et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in the Netherlands. Clin Infect Dis 2007; 45:695-703. (Pubitemid 47378882)
7. Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23:529-49.
8. Hubert B, Loo VG, Bourgault AM, et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007; 44:238-44. (Pubitemid 46079988)
9. Kenneally C, Rosini JM, Skrupky LP, et al. Analysis of 30-day mortality for clostridium difficile-associated disease in the ICU setting. Chest 2007; 132:418-24. (Pubitemid 47282371)
10. Goorhuis A, Bakker D, Corver J, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47:1162-70.
11. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173:1037-42.
12. Gravel D, Miller M, Simor A, et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009; 48:568-76.
13. Office for National Statistics. Deaths involving Clostridium difficile: England and Wales, 1999 and 2001-06. Health Stat Q 2008 Spring; 52-6.
14. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficilerelated mortality rates, United States, 1999-2004. Emerg Infect Dis 2007; 13:1417-9. (Pubitemid 47510317)
15. Labbe AC, Poirier L, Maccannell D, et al. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 2008; 52:3180-7.
16. Dubberke ER, Butler AM, Reske KA, et al. Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008; 14:1031-8. (Pubitemid 351920431)
17. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83. (Pubitemid 17055592)
18. Bidet P, Lalande V, Salauze B, et al. Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 2000; 38:2484-7. (Pubitemid 30487377)
19. World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD- 10). Geneva, Switzerland: WHO, 1992.
20. Office for National Statistics (2010). Deaths involving Clostridium difficile: England and Wales, 2006 to 2010. Available at: www.ons.gov.uk/ ons/rel/subnational-health2/deaths-involving-clostridium-difficile/2006- to-2010/statistical-bulletin.html. Accessed 20 December 2011.
21. Oake N, Taljaard M, van WC, et al. The effect of hospital-acquired Clostridium difficile infection on in-hospital mortality. Arch Intern Med 2010; 170:1804-10.
22. Fifth Annual Report of the National Reference Laboratory for Clostridium difficile (May 2010 to May 2011) and results of the sentinel surveillance. Available at: www.rivm.nl/Bibliotheek/Algemeen-Actueel/ Uitgaven/ Infectieziekten/Fifth-Annual-Report-of-the-National-Refer ence-Laboratory-for- Clostridium-difficile-May-2010-to-May-2011- and-results-of-the-sentinel- surveillance. Accessed 1 March 2012.
23. Mlangeni DA, Harris MD, Franklin L, et al. Death certificates provide a poor estimation of attributable mortality due to Clostridium difficile when compared to a death review panel using defined criteria. J Hosp Infect 2011; 77:370-1.
24. Hota SS, Achonu C, Crowcroft NS, et al. Determining mortality rates attributable to Clostridium difficile infection. Emerg Infect Dis 2012; 18:305-7.
25. Shears P, Prtak L, Duckworth R. Hospital-based epidemiology: a strategy for 'dealing with Clostridium difficile.' J Hosp Infect 2010; 74:319-25.
26. Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377:63-73.
27. Morgan OW, Rodrigues B, Elston T, et al. Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS One 2008; 3: e1812.
28. Garey KW, Graham G, Gerard L, et al. Prevalence of diarrhea at a university hospital and association with modifiable risk factors. Ann Pharmacother 2006; 40:1030-4. (Pubitemid 43886958)
29. Thomas C, Stevenson M, Riley TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 2003; 51:1339-50. (Pubitemid 36748921)
30. Eastwood K, Else P, Charlett A, et al. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009; 47:3211-7.